Claro Banner 1 - edit

Empower your research flow with Claro™ bio-ink

Best-in-class reliability and batch-to-batch consistency

 

 

 

Regemat

Claro’s excellent bio-printing properties

  • Reliable
  • Proven cell viability
  • Crosslinkable

Bioprintable gels (BG) product line

Latest news

  • Claro is a brand of Tessenderlo Group that helps researchers in the field of tissue engineering

    Claro joins forces with Regemat 3D

    Claro has now joined forces with Regemat 3D (a biotech company pioneer in the design and development of customized 3D bioprinters and bioreactors for research in the regenerative medicine field), which will now distribute Claro’s BG800 that was developed for extrusion-based bioprinters.

    Insights - blog

    Read more

  • Claro blog 1

    Claro acknowledges that bioprinting will help periodontal therapy advance

    Periodontal (gum) disease: an annual cost estimated at 79 billion euros in Europe Periodontal (gum) disease is extremely common. Severe periodontal diseases are found in 5–20% of middle-aged (35–44 years) adults in Europe, and up to 40% of older people (65–74 years). Diseases of the mouth are an expensive burden to health care services.

    Insights - blog

    Read more

  • Claro - Blog 2.png

    GelMA by Claro: great potential to build 3D models that mimic real tumors

    The need for innovative 3D cancer models to enhance drug-testing process The National Cancer Institute defines cancer as “a term for diseases in which abnormal cells divide without control and can invade nearby tissues. Cancer cells can also spread to other parts of the body through the blood and lymph systems.” [1]. Metastases are the primary...

    Insights - blog

    Read more

Empower the flow of your research

Contact our team